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Abstract 14 
The growth performance, immunological status, intestinal morphology and microbiology of 15 
tilapia, Oreochromis niloticus, were investigated after dietary administration of the 16 
commercial probiotic AquaStar® Growout. Tilapia (29.02 ± 0.33g) were split into five 17 
treatments; control (CON), 1.5g kg-1 probiotic (PRO-1.5), 3g kg-1 probiotic (PRO-3), pulsed 18 
probiotic feeding (PRO-PULSE) or an initial probiotic feed followed by control feeding 19 
(PRO-INI). After six weeks of experimental feeding, fish fed PRO-3 displayed significantly 20 
higher final weight, weight gain and SGR compared to the CON or PRO-INI treatments. 21 
Supplementation of the probiotic at this dose induced an up-regulation of intestinal caspase-3, 22 
PCNA and HSP70 mRNA levels compared to the CON fed fish. Immuno-modulatory 23 
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pathways were also affected; significantly higher expression of TLR2, pro-inflammatory 24 
genes TNFα and IL-1β, and anti-inflammatory genes IL-10 and TGFβ suggest that the 25 
probiotic may potentiate a higher state of mucosal tolerance and immuno-readiness. 26 
Histological appraisal revealed significantly higher numbers of intraepithelial leucocytes in 27 
the intestine of PRO-3 fed fish compared with treatments CON, PRO-PULSE and PRO-INI 28 
but not PRO-1.5. Additionally, fish receiving PRO-3 had a significantly higher abundance of 29 
goblet cells in their mid-intestine when compared with fish from all other treatments. 30 
Together, these data suggest that continuous provision of AquaStar® Growout at 3g kg-1 can 31 
improve tilapia growth and elevate the intestinal immunological status of the host.  32 
 33 
Keywords: probiotic; tilapia; fish; immunity; gene expression; growth performance; 34 
histology, intestinal microbiology. 35 
 36 
1 Introduction 37 
Aquaculture continues to be the fastest growing animal protein production industry [1]. As a 38 
result of extensive research, probiotics are becoming an increasingly popular choice as a 39 
prophylactic approach to avoid disease and improve health and production of farmed fish, 40 
including tilapia.  41 
A number of probiotic investigations have focused on growth benefits in tilapia, with many 42 
studies reporting positive results after probiotic supplementation [2-8]. As well as strong 43 
growth performance, it is important that fish are healthy and capable of mounting an effective 44 
immune response when exposed to pathogens. The gastrointestinal (GI) tract plays an 45 
important role in the mucosal barrier function. Not only does it serve as a physico-chemical 46 
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barrier against invading pathogens, there are also tolerance mechanisms in place which allow 47 
the residence of commensal and mutualistic microbes [9]. Probiotics can have beneficial 48 
effects on the gut-associated lymphoid tissues (GALT). These benefits can manifest 49 
themselves within the intestine by means of reinforcing barrier defences by elevating 50 
populations of intra epithelial leucocytes and goblet cells and also by inducing the expression 51 
of pro-inflammatory cytokines (e.g. TNFα, IL-1β), thus maintaining the capacity of 52 
recognising and responding to pathogens, and regulatory cytokines (e.g. TGFβ, IL-10) for the 53 
maintenance of mucosal tolerance [10-15]. These cytokines are the end products of complex 54 
molecular pathways which are initiated by toll-like receptors (TLR’s) recognising their 55 
corresponding microbe associated molecular pattern (MAMP) [16]. Probiotic 56 
supplementation can up-regulate the expression of intestinal TLR3 in Atlantic salmon, Salmo 57 
salar, and intestinal TLR2 and TLR5 in grouper, Epinephelus coioides, with a corresponding 58 
induction of intestinal IL-1β, TNFα, IL-8 and TGFβ expression [17, 18].  59 
Currently, there are multiple probiotic formulations commercially available. It is essential 60 
that probiotic candidates are evaluated for efficacy and the dosage and feeding regime should 61 
be optimised [19]. The current investigation aimed to evaluate multiple doses and feeding 62 
regimes of a commercially available multi-species probiotic, AquaStar® Growout (a mix of 63 
Bacillus subtilis, Enterococcus faecium, Lactobacillus reuteri and Pediococcus acidilactici at 64 
1 x 109 CFU g-1), on tilapia growth performance, intestinal integrity, intestinal microbiology 65 
and intestinal immunity.  66 
 67 
 68 
 69 
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2 Materials and methods 70 
2.1 Experimental design and dietary preparation 71 
All experimental work involving fish was conducted under the Home Office project licence 72 
PPL30/2644 and was in accordance with the Animals (Scientific Procedures) Act 1986 and 73 
the Plymouth University Ethical Committee.  74 
Three iso-nitrogenous and iso-lipidic diets were formulated using Feedsoft Professional® 75 
according to the known requirements of tilapia [20] (Table 1). Dry ingredients were mixed in 76 
small batches to ensure a homogenous mix before adding the oil and warm water in a Hobart 77 
food mixer (Hobart Food equipment, Australia) to form a consistency suitable for cold press 78 
extrusion (PTM P6 extruder, Plymouth, UK) to produce 2mm pellets. The lyophilised 79 
probiotic (AquaStar® Growout; Biomin GmbH) was added at the expense of corn starch and 80 
the basal diet void of the probiotic served as a control diet. Diets were dried for 24 hours in 81 
an air convection oven set to 44°C, broken up by hand and stored in refrigerated air tight 82 
containers prior to use. The dietary proximate composition was analysed using AOAC 83 
protocols [21] (Table 1). Probiotic viability was checked using selective media (de Man, 84 
Rogosa and Sharpe (MRS) media, Bacillus selective agar and Slanetz and Bartley media for 85 
Lactobacillus/Pediococcus, Bacillus and Enterococcus spp., respectively) by spread plating 86 
10-fold serial dilutions and counting statistically viable plates (i.e. 20-200 colonies). Fresh 87 
diets were produced at the trial midpoint to ensure high probiotic viability. 88 
Nile tilapia, Oreochromis niloticus, (Fishgen Ltd., Swansea, UK), were transferred to the 89 
Aquaculture and Fish Nutrition Research Aquarium, Plymouth University, UK where they 90 
were allowed six weeks of acclimation. Five hundred tilapia were randomly distributed to ten 91 
150L fibreglass tanks (50 fish per tank; average weight = 29.02 ± 0.33g; n = 2). Treatments 92 
were as follows; control (basal diet void of AquaStar® Growout), low probiotic dose 93 
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(continuous feeding of the basal diet supplemented with AquaStar® Growout at 1.5g kg-1), 94 
high probiotic dose (continuous feeding of the basal diet supplemented with AquaStar® 95 
Growout at 3 g kg-1), probiotic pulse feeding (alternating weekly between AquaStar® 96 
Growout feeding at 1.5g kg-1 and control feeding) and lastly initial probiotic feeding (first 97 
two weeks AquaStar® Growout feeding at 1.5g kg-1 followed by remainder of the trial on the 98 
control diet). Diet codes were assigned for ease of analysis (Table 2). Fish were fed 99 
experimental diets for six weeks at a rate of 1- 5% biomass per day in four equal rations (all 100 
treatments received the same % input each day); higher feeding rates were provided at the 101 
beginning of the trial but this was decreased incrementally during the trial as fish grew larger 102 
and their appetite decreased. Daily feed was adjusted on a weekly basis by batch weighing 103 
following a 24 hour starvation period. Fish were held at 28 ± 1°C with a 12:12 h light: dark 104 
photoperiod. Water quality was monitored daily and maintained at pH = 6.5 ± 0.5 (adjusted 105 
with NaHCO3 as necessary) and dissolved oxygen > 6.0 mg l-1. Ammonium, nitrite and 106 
nitrate levels were monitored weekly (0.08 ± 0.02, 0.15 ± 0.05 and 18.30 ± 3.30 mg l-1, 107 
respectively) and regular water changes prevented the accumulation of these compounds as 108 
well as preventing background build-up of probiotics. 109 
 110 
2.2 Growth performance and carcass composition 111 
Growth performance and feed utilisation were assessed by net weight gain (NWG), feed 112 
intake (FI), specific growth rate (SGR), feed conversion ratio (FCR) and protein efficiency 113 
ratio (PER). Calculations were carried out using the following formulae: NWG = FW - IW; 114 
SGR = 100 ((ln FW - ln IW)/T); FCR = FI/WG; PER = WG/PI, where FW = final weight (g), 115 
IW = initial weight (g), T = duration of feeding (days), WG = wet weight gain (g), FI = feed 116 
intake (g) and PI = protein ingested (g). At the end of the trial four fish per tank were pooled 117 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
into two samples (thus n = 4) to determine final carcass composition. Proximate composition 118 
analysis was conducted according to AOAC protocols [21].  119 
 120 
2.3 RT-PCR 121 
The mid-intestine was sampled from four fish per tank (n = 8) for gene expression of caspase-122 
3, PCNA, HSP70, TLR2, TGFβ, IL-10, TNFα and IL-1β after six weeks. Total RNA was 123 
extracted using TRIzol (Invitrogen) according to the manufacturer’s protocol as described in 124 
Rawling et al. [22] with the addition of an extra isopropanol step. RNA concentration and 125 
purity was measured spectophotometrically (NanoDrop Technologies) and RNA integrity 126 
was checked by running each sample on a 1% agarose gel. Any samples with DNA 127 
contamination were cleaned using RNeasy MiniElute Cleanup Kit (Qiagen). RNA samples 128 
were subsequently stored at -80°C until use.  129 
A total concentration of 1 µg of RNA was used for cDNA synthesis using iScript cDNA 130 
Synthesis Kit (BioRad) according to manufacturer’s instructions. Primer efficiencies were 131 
determined using serial 1/10 dilutions of pooled cDNA and resulting plots of Ct versus the 132 
logarithmic cDNA input, using the equation E = 10(-1/slope). Primer sequences and efficiencies 133 
are reported in Table 3. PCR reactions were run in duplicate (total reaction volume = 7.5 µl) 134 
were set on a 384-well plate and each reaction consisted of 2 µl of cDNA (1/10 dilution), 135 
3.75 µl of 2X concentrated SYBR Green Supermix (Biorad), 0.225 µl of each forward and 136 
reverse primers (0.3 µM) and 1.3 µl of DEPC treated water (Ambion). All quality control 137 
measures and RT-reactions were carried out according to the MIQE guidelines [23]. The 138 
thermal profile for all reactions were 10 min at 95°C and then 40 cycles of 15s at 95°C and 139 
60s at 60°C. Fluorescence monitoring occurred at the end of each cycle and melt curve 140 
analyses were performed in all cases to check for a single peak. GAPDH, β-actin and EF1-α 141 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
were all assessed as reference genes. Reference genes were imported into GeNorm (v 3.4, 142 
Center for Medical Research, Ghent University, Belgium) to assess the optimal number, and 143 
choices of reference genes. Experimental treatments were each compared to the control and 144 
analysed using the relative expression software tool (REST©) [24] and reported as fold 145 
change. 146 
 147 
2.4 Intestinal histology 148 
Four tilapia per tank were sampled at week six (n = 8) for histological appraisal of the mid-149 
intestine. Tissue samples were fixed in 10% formalin and transferred to 70% ethanol after 48 150 
hours. Samples were then dehydrated in graded ethanol concentrations prior to embedding in 151 
paraffin wax. In each specimen, multiple sections (5µm) were stained with haematoxylin and 152 
eosin (H & E) and Alcian Blue-PAS to assess the intestinal perimeter ratio (arbitrary units; 153 
AU) after Dimitroglou et al. [25], intraepithelial leucocytes (IEL’s) levels and goblet cell 154 
abundance in the epithelium. IEL’s and goblet cells were counted across a standardized 155 
distance of 100 µm and then calculated by averaging the cell numbers from all samples 156 
within each treatment. All light microscopy images were analysed with Image J 1.46r 157 
(National Institute of Health, USA). 158 
 159 
2.5 Intestinal microbiological analyses 160 
After the experimental period, four fish per tank were euthanized by overdose (300mg l-1) of 161 
tricaine methane sulphonate (MS222; Pharmaq, Fordingbridge, UK). The GI tract was 162 
aseptically removed in its entirety. Faecal matter from the mid-intestine was isolated, and 163 
pooled between two fish (thus n = 4 per treatment) to assess allochthonous bacterial 164 
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populations. Intestinal samples were either used immediately for culture based analysis or 165 
stored at -20°C for culture independent analysis. 166 
 167 
2.5.1 Culture dependent analysis 168 
Samples were serially diluted with PBS and 20µl was spotted onto duplicate MRS agar, 169 
Slanetz and Bartley and Bacillus selective media using the Miles and Misra method [26] to 170 
assess the allochthonous presumptive probiotic bacterial populations. Tryptone soya agar 171 
(TSA) was used to determine the total aerobic heterotrophic bacterial populations. Plates 172 
were incubated for 48 hours at 28°C and colony forming units (CFU g-1) were calculated by 173 
counting colonies from statistically viable plates (between 3-30 colonies). Representative 174 
subsets of the presumptive probiotics were identified by using 16S rRNA gene sequence 175 
analysis using the protocol described in Ferguson et al. [27].  176 
 177 
2.5.2 Culture independent analysis 178 
At week six, digesta samples (n = 4) were used for culture independent analyses. DNA was 179 
extracted using the QIAamp Stool Mini Kit (Qiagen) with a lysozyme pre-treatment (50 mg 180 
mL-1 in TE buffer for 30 min at 37°C) and a phenol-chloroform clean up, as described [28]. 181 
PCR amplification of the 16S rRNA V3 region was conducted using the reverse primer P2 182 
and the forward primer P3 [29]. A 40-60% DGGE was performed, and presumptive probiotic 183 
bands extracted, using a DCode Universal Mutation Detection System (Bio-Rad laboratories, 184 
Italy) according to Merrifield et al [30]. The presumptive probiotic nucleotide sequences 185 
were submitted to a BLAST search to retrieve the closest known alignment identities.  186 
 187 
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2.6 Statistical analyses 188 
All data are presented as means ± standard deviation. All data were checked for normality 189 
and analysed using ANOVA with post-hoc Tukey’s HSD test (Statgraphics Centurion XVI, 190 
Warrenton, VA, USA). Where data were not normally distributed, data were analysed using a 191 
Kruskal- Wallis test with post-hoc Mann-Whitney U-tests. RT-PCR data were analysed using 192 
REST© 2009 (Qiagen, Hilden, Germany). DGGE banding patterns were transformed into 193 
presence/ absence matrices based on band peak intensities (Quantity One® version 4.6.3, Bio-194 
Rad Laboratories, CA, USA). Band intensities were measured (Quantity One® 1-D Analysis 195 
Software, Bio-Rad Laboratories Ltd., Hertfordshire, UK), and analysed using Primer V6 196 
software (PRIMER-E Ltd, Ivybridge, UK). In all cases, significance was accepted at P < 0.05. 197 
 198 
3 Results 199 
3.1 Growth performance and carcass composition 200 
Growth performance was assessed by means of routine growth and feed utilisation 201 
parameters after six weeks of feeding experimental feeding (Table 4). Tilapia fed the PRO-3 202 
diet displayed the best growth performance. In this treatment the final weight, weight gain 203 
and SGR were significantly higher when compared to either CON or PRO-INI (P = 0.019, 204 
0.014 and 0.021, respectively). However, they did not significantly differ from treatments 205 
PRO-1.5 or PRO-PULSE. No differences in feed intake, PER or FCR were observed between 206 
any treatment (P = 0.054, 0.190 and 0.237, respectively). Additionally, there were no 207 
significant differences in carcass proximal composition (Table 4).  208 
 209 
 210 
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3.2 RT-PCR 211 
Relative intestinal gene expression of caspase-3, PCNA, HSP70, TLR2, TNFα, IL-1β, IL-10 212 
and TGFβ were analysed. The largest fold change was observed in caspase-3 mRNA levels 213 
which were up-regulated approximately seven fold in PRO-3 when compared to the control 214 
group (P = 0.001). The gene expression of PCNA and HSP70 were six and three and half 215 
times higher in PRO-3, respectively, when compared to the control treatment (P < 0.001 and 216 
0.028 respectively; Figure 1).  217 
Further changes were observed for the immunity related genes (Figure 2). TLR2 mRNA 218 
expression was significantly up-regulated, more than four fold, in PRO-3 when compared to 219 
the control treatment (P = 0.004). The pro-inflammatory cytokine genes TNFα and IL-1β 220 
were up-regulated three and five times, respectively, in the intestine of the PRO-3 fed fish 221 
compared to the CON fed fish (P = 0.028 and 0.003, respectively). Furthermore, tolerogenic 222 
cytokine IL-10 and TGFβ mRNA levels were also up-regulated by approximately five and six 223 
fold, respectively, in PRO-3 when compared to the control treatment (P = 0.005 and 0.003, 224 
respectively).  225 
There were no significant changes in gene expression between any of the investigated genes 226 
between treatments PRO-1.5, PR0-PULSE and PRO-INI when compared to the control 227 
treatment (P > 0.05). 228 
 229 
3.3 Intestinal histology 230 
Light microscopy was used to examine the perimeter ratio, IEL and goblet cell levels from 231 
the mid-intestine (Table 5). Fish from all dietary treatments had an intact epithelial barrier 232 
with extensive mucosal folds, abundant IEL’s and numerous goblet cells. Tilapia in different 233 
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treatments showed altered perimeter ratios (P = 0.007). The highest perimeter ratio was 234 
recorded in PRO-INI which was significantly higher than PRO-1.5 but not CON, PRO-3 or 235 
PRO-PULSE. Perimeter ratio in PRO-3 was also significantly higher when compared to the 236 
lower probiotic dose, PRO-1.5. However, perimeter ratio remained unchanged between 237 
treatments PRO-1.5, CON, and PRO-PULSE. IEL and goblet cell abundance remained 238 
unchanged by dietary treatment in groups CON, PRO-1.5, PRO-PULSE and PRO-INI. 239 
However, IEL levels were significantly elevated in PRO-3 when compared to treatments 240 
CON, PRO-PULSE and PRO-INI (P < 0.05) but not PRO-1.5. PRO-3 also contained 241 
significantly larger populations of goblet cell when compared to all other treatments (P < 242 
0.001; Table 5). 243 
 244 
3.4 Culture dependent analysis 245 
The effect of AquaStar® Growout treatment on the aerobic heterotrophic bacteria was 246 
determined using culture based methods (Table 6). No significant differences were observed 247 
in TVC levels between the treatments with allochthonous levels approximately log 6 CFU g-1 248 
for each treatment (P = 0.993). The highest LAB levels were observed in the digesta of PRO-249 
3 fed tilapia, these were significantly higher than of CON and PRO-INI (P = 0.006). 250 
Similarly, PRO-3 resulted in the highest Bacillus levels which were significantly higher than 251 
those found in PRO-PULSE but not in other treatments (P = 0.026). LAB and Bacillus 252 
populations were not different in treatments CON, PRO-1.5, PRO-PULSE and PRO-INI. 253 
Furthermore, enterococci levels were significantly higher in PRO-3 when compared to CON, 254 
PRO-PULSE and PRO-INI. Despite being numerically higher, they were not different to 255 
enterococci levels recovered in PRO-1.5 digesta. Representative subsets of the presumptive 256 
probiotics were confirmed as the probiotics by 16S rRNA gene sequence analysis. 257 
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3.5 DGGE 258 
The influence of dietary AquaStar® Growout on the intestinal microbial diversity in tilapia 259 
was investigated using DGGE after six weeks of feeding experimental diets. Presumptive 260 
probiotic bands were identified by migration to the same position as known B. subtilis, E. 261 
faecium, L. reuteri and P. acidilactici samples. These bands were also isolated from DGGE 262 
gels and subsequent sequencing confirmed the presence of all four probiotic species from 263 
AquaStar® Growout fingerprints; these were not detected in control sample fingerprints. 264 
Table 7 displays the microbial ecological parameters derived from the DGGE fingerprints. 265 
There were no significant differences between treatments with regards to number of OTU’s 266 
(N), species richness or diversity indices (P = 0.083, 0.086 and 0.102, respectively). 267 
Replicates from CON and PRO-PULSE showed the highest similarity percentage (SIMPER), 268 
this was significantly higher than replicates in PRO-1.5 but not those in PRO-3 or PRO-INI. 269 
Apart from PRO-1.5, all other treatments displayed no differences with regards to SIMPER 270 
analyses. ANOSIM revealed that the microbial communities within PRO-3 fed tilapia were 271 
significantly dissimilar to CON, PRO-PULSE and PRO-INI (53.35%, 58.25% and 58.10% 272 
dissimilar, respectively; P = 0.03) but not PRO-1.5 (34.54% dissimilar; P = 0.23). 273 
Additionally, the microbial community within PRO-1.5 was significantly dissimilar to the 274 
microbial community within the intestine of PRO-PULSE (40.33% dissimilar; P = 0.03). 275 
This can be visualised in Figure 3 where there is a clustering effect of the communities from 276 
the PRO-3 replicates. Replicates from treatments CON, PRO-PULSE and PRO-INI showed 277 
loose clustering with level of overlap between these three treatments. Two out of four 278 
replicates from PRO-1.5 show high similarity to those from PRO-3, whereas the remaining 279 
two replicates are more similar to the other treatments (Figure 3).  280 
  281 
 282 
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 4 Discussion 283 
The administration of AquaStar® Growout at 3g kg-1 for six weeks resulted in improved 284 
growth performance when compared to treatments CON or PRO-INI.  AquaStar® Hatchery 285 
(which contains a higher concentration of the same probiotic strains as AquaStar® Growout) 286 
has previously been reported to improve growth performance of rainbow trout 287 
(Oncorhynchus mykiss) [31]. Although there is no data regarding the growth promoting 288 
effects of AquaStar® Growout in tilapia, dietary provision of Bacillus spp., Enterococcus spp. 289 
and Lactobacillus spp., either singularly or in combination with other species have been 290 
reported to improve tilapia growth performance indicators [2, 4-8, 32-35]. The mechanisms 291 
which underpin these improvements are only partly described. Previous work on tilapia 292 
suggests that Aquastar® Growout may increase the intestinal absorptive surface area by 293 
improving the microvilli density and microvilli length [36]. Probiotics may also be important 294 
in the production of digestive enzymes. Essa et al. [6] reported elevated intestinal amylase, 295 
protease and lipase activities in tilapia supplemented with B. subtilis and/ or L. rhamnosus 296 
and elevated intestinal protease activity in fish supplemented with S. cerevisae.  297 
Heat shock proteins have important roles in protein metabolism, protein folding, protein 298 
chaperoning, mediating the repair and degradation of damaged proteins and are also involved 299 
in generating an immune response [38]. Furthermore it has also been proposed that heat 300 
shock proteins play important roles in the long term adaptation of animals to their 301 
environments through genetic mechanisms [39]. Fish exhibiting higher HSP70 expression 302 
may therefore be more able to generate an efficient immune response and also be more 303 
tolerant to a wider range of environmental conditions. In the present study gene expression 304 
analyses were used to elucidate the effect of the probiotic treatment on the mid-intestine at 305 
the molecular level. Many authors have reported lower expression of HSP70 after probiotic 306 
administration in fish [40-42] including tilapia [11]. Here, intestinal HSP70 gene expression 307 
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showed the opposite trend as it was significantly higher in PRO-3 when compared to the 308 
control. Using an ex vivo approach, Ren et al. [13] demonstrated that exposure to Aeromonas 309 
hydrophila did not cause an upregulation of HSP70 in the anterior or posterior intestine of 310 
tilapia. Conversely, the addition of Lactobacillus plantarum, as well as a mix of A. 311 
hydrophila and L. plantarum to the intestinal sac caused an upregulation of HSP70 [13]. 312 
Similar results were reported by Liu et al. [12] after the feeding hybrid tilapia, O. niloticus x 313 
Oreochromis aureus, diets supplemented with two Lactobacillus species. From their studies 314 
it was also evident that there appears to be a dosage, as well as temporal effect. For example, 315 
after 10 days of feeding on the probiotic diet, intestinal HSP70 was significantly up-regulated, 316 
down-regulated after 20 days and not different after 35 days when compared to the control 317 
treatment.  318 
Caspase-3 and PCNA gene expression were both significantly up-regulated in PRO-3 when 319 
compared with the control group. Caspase-3 is part of the cysteine-aspartic acid protease 320 
family where it is activated by initiator caspases-8 or 9 resulting in programmed cell death 321 
(apoptosis). On the other hand, PCNA (proliferating cell nuclear antigen) is a marker for cell 322 
proliferation and is crucial for cellular and DNA replication. Organised apoptosis is essential 323 
for the health of the host since it results in the elimination of dangerous or damaged cells 324 
without causing an inflammatory response or tissue damage [43]. Since the GI tract is one of 325 
the key sites of interaction with the external environment [44] the intestine could be exposed 326 
to a number of opportunistic pathogens or chemical contaminants, especially in aquaculture 327 
where high stocking densities and water quality can be problematic. Therefore, both an 328 
elevated proliferative and apoptotic capacity is likely to be beneficial to the host.  329 
The gut associated lymphoid tissue (GALT) in fish differs from their mammalian 330 
counterparts since fish lack Peyer’s patches and mesenteric lymph nodes. Teleosts possess a 331 
more diffusely organised GALT which provides a physical, chemical and cellular barrier to 332 
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pathogenic invasion [9]. Similar to mammalian models, immune and epithelial cells within 333 
the GALT of fish express pattern recognition receptors (PRR’s) including toll-like receptors 334 
(TLR’s), which are sensitive to a number of pathogen associated molecular patterns 335 
(PAMP’s). Upon ligation, a cascade effect is initiated through a series of adaptor proteins and 336 
transcription factors resulting in the transcription of important immune molecules such as 337 
cytokines, chemokines and defensins [9]. 338 
TLR2 gene expression was up-regulated in PRO-3 when compared with the control treatment. 339 
TLR2 is ligated by lipoteichoic acid (LTA), which is a major constituent in the cell wall of 340 
Gram-positive bacteria [45], such as those present in AquaStar® Growout. This up-regulation, 341 
induced by Gram-positive probiotics might be of particular importance because tilapia are 342 
susceptible to a number of Gram-positive infections, in particular Streptococcus iniae and 343 
Streptococcus agalactiae. Indeed, TLR2 was up-regulated in Mrigal carp (Cirrhinus mrigala) 344 
following Streptococcus uberis infection as well as A. hydrophila infection [46], another 345 
destructive pathogen in tilapia culture. It has been demonstrated that TLR’s may have 346 
important roles to play in the probiotic modulation of the innate immune system in other fish 347 
species [17, 18]. Sun et al. [18] reported an upregulation in both TLR2 and TLR5 in grouper 348 
(Epinephelus coioides) after Psychrobacter sp. supplementation. Furthermore, the authors 349 
demonstrated a higher expression of pro-inflammatory genes IL-1β and IL-8, and the anti-350 
inflammatory gene TGFβ after probiotic supplementation. The present study also reports 351 
higher gene expression of both pro-inflammatory cytokines (TNFα and IL-1β) and anti-352 
inflammatory cytokines (IL-10 and TGFβ) after probiotic administration at 3g kg-1 when 353 
compared to the control treatment. Here, despite the up-regulation of pro-inflammatory 354 
cytokines, there was no evidence of inflammation from histology examinations. It is possible 355 
that this was balanced by the up-regulation of anti-inflammatory cytokine gene expressions. 356 
Other authors have reported higher expression of pro-inflammatory cytokines in tilapia after 357 
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probiotic feeding [10-15]. It is postulated that the induction of pro-inflammatory cytokines 358 
improves immune readiness of the host. In support of this, disease resistance studies in tilapia 359 
have demonstrated that probiotics are able to increase the expression of TNFα and IL-1β and 360 
consequently the tilapia survival levels were significantly higher when exposed to A. 361 
hydrophila [12, 15].  362 
The current study also demonstrated that the probiotics also have anti-inflammatory 363 
signalling effects, by inducing the up-regulation of TGFβ and IL-10. Naturally, anti-364 
inflammatory cytokines will have an immune-suppressive effect on the host; this could be 365 
indicative of a tolerance mechanism where the host does not interpret the probiotic as a threat. 366 
This has been demonstrated in other fish studies where TGFβ was up-regulated after 367 
probiotic administration [11, 12]. To the authors knowledge this is the first study to 368 
demonstrate probiotic modulation of IL-10 in the intestine of tilapia after probiotic feeding. 369 
However, similar results have been reported in rainbow trout after L. plantarum 370 
supplementation [47]. 371 
Histological analyses revealed significantly larger populations of IEL’s in the mid-intestine 372 
of tilapia in PRO-3 when compared to treatments CON, PRO-PULSE or PRO-INI. Similar 373 
results have been obtained in other studies using tilapia fed diets supplemented with either P. 374 
acidilactici or Lactobacillus rhamnosus for six weeks and 30 days, respectively [10, 14]. 375 
Probiotic administration has led to increased IEL abundance in other commercially important 376 
fish species including European sea bass (Dicentrarchus labrax) and gilthead sea bream 377 
(Sparus aurata) [48, 49]. Whilst the type of IEL cannot be eluded to in this study, Picchietti 378 
et al. [49] characterised elevated T-cells and acidophilic granulocytes in the posterior 379 
intestine of European sea bass. These data suggest that probiotics not only act upon the innate 380 
immune system in fish, but may have important roles to play through adaptive immunity 381 
mechanisms too.  382 
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Whilst all fish displayed abundant goblet cells within the intestine, there were significantly 383 
larger populations in the mid-intestine of tilapia fed PRO-3 when compared to all other 384 
treatments. Intestinal mucus is vital to the defensive barrier, both physically and chemically, 385 
since it functions to trap and remove pathogens, preventing their attachment to the epithelia. 386 
Dietary applications of L. rhamnosus and P. acidilactici have also been reported to increase 387 
the number of goblet cells in the tilapia intestine [14, 50].  388 
This study was successful in recovering each probiotic species from tilapia digesta, a 389 
requirement which is essential for any probiotic candidate. Furthermore, probiotic 390 
supplementation was capable of modulating the composition of intestinal microbiota. This 391 
supports a previous study which also reported the detection of these probiotic species, and 392 
modulation of the intestinal microbiota, of tilapia using DGGE and high-throughput 393 
sequencing [36].  394 
In conclusion, under the current experimental conditions, the continuous supplementation of 395 
AquaStar® Growout at 3g kg-1 can improve growth performance and elevate the intestinal 396 
immunological status in tilapia. The probiotic may act to augment mucosal tolerance 397 
mechanisms whilst creating a state of immune readiness, improved barrier function through 398 
the increase the number of goblet cells and IELs in the intestine, which may ultimately retard 399 
pathogen infection and translocation. Future studies should assess these using challenge trials.  400 
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 413 
Figure 1: Relative mid-intestinal gene expression of caspase-3 and PCNA and HSP70 after 414 
six weeks of feeding experimental diets. Values are reported in fold change when compared 415 
against the expression in the control treatment (set to 1.0). Asterisks highlight significant 416 
differences (P < 0.05) when compared to the control treatment. 417 
 418 
Figure 2: Relative gene expression of mid-intestinal TLR2 receptor (A) pro-inflammatory 419 
cytokines TNFα (B) and IL-1β (C) and anti-inflammatory cytokines TGFβ (D) and IL-10 (E) 420 
and after six weeks of feeding experimental diets. Values are reported in fold change when 421 
compared against the expression in the control treatment (set to 1.0). Asterisks highlight 422 
significant differences (P < 0.05) when compared to the control treatment. 423 
 424 
Figure 3: nMDS plot showing similarity of the intestinal allochthonous microbiota of each 425 
treatment after six weeks of feeding experimental diets. Lines represent different levels of 426 
similarity.  427 
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Table 1: Dietary formulation and chemical composition (%). 428 
 Basal 1.5g kg-1 3g kg-1 
Fishmeala  10.00 10.00 10.00 
Soyabean mealb  33.89 33.89 33.89 
Corn Starchc  31.90 31.75 31.60 
Lysamine pea proteind  5.00 5.00 5.00 
Glutalysd  10.00 10.00 10.00 
Fish oil 3.75 3.75 3.75 
Corn oil  4.00 4.00 4.00 
Vitamin& mineral premixf  0.50 0.50 0.50 
CMC-binderc  0.50 0.50 0.50 
Methioninec 0.36 0.36 0.36 
AquaStar® Growoutg  0.00 0.15 0.30 
Proximate composition (% as fed basis)  
Moisture  7.16 ± 0.03 5.89 ± 0.09 8.23 ± 0.19 
Crude protein  37.57 ± 0.16 38.08 ± 0.30 37.03 ± 0.13 
Lipid  10.09 ± 0.03 10.61 ± 0.24 10.41 ± 0.09 
Ash  4.29 ± 0.04 4.25 ± 0.07 4.20 ± 0.01 
Energy (MJ kg-1) 19.72 ± 0.05 19.57 ± 0.40 18.97 ± 0.19 
a Herring meal LT92 – United Fish Products Ltd., Aberdeen, UK.  429 
b Hamlet HP100, Denmark.  430 
c Sigma- Aldrich Ltd., UK.  431 
d Roquette Frêres, France. 432 
e
 Natural wheat bran, Holland & Barrett, UK.   433 
f Premier nutrition vitamin/mineral premix contains: 121 g kg-1 calcium, Vit A 1.0 µg kg-1, 434 
Vit D3 0.1 µg kg-1, Vit E (as alpha tocopherol acetate) 7.0 g kg-1, Copper (as cupric sulphate) 435 
250 mg kg-1, Magnesium 15.6 g kg-1, Phosphorous 5.2 g kg-1.  436 
g Biomin Holding GmbH, Industriestrasse 21, 3130 Herzogenburg, Austria. 437 
 438 
 439 
 440 
 441 
 442 
 443 
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Table 2: Dietary codes used throughout the research article. 444 
Dietary code Diet 
CON Continuous feeding of basal diet (without probiotic) 
PRO-1.5 Continuous feeding of the basal diet supplemented with AquaStar® 
Growout at 1.5g kg-1 
PRO-3 Continuous feeding of the basal diet supplemented with AquaStar® 
Growout at 3g kg-1 
PRO-PULSE Alternating weekly between AquaStar® Growout feeding at 1.5g kg-1 
and the basal diet 
PRO-INI Initial two weeks AquaStar® Growout feeding at 1.5g kg-1 followed by 
remainder of the trial on the basal diet 
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Table 3: Primer sequences used for RT-PCR 445 
Gene Forward 5’ - 3’ Reverse 5’ – 3’ Amplicon 
size 
Tm 
(°C) 
E-
value 
GenBank number 
β-actin TGACCTCACAGACTACCTCATG TGATGTCACGCACGATTTCC 89 58.8 2.1 KJ126772.1 
GAPDH CCGATGTGTCAGTGGTGGAT GCCTTCTTGACGGCTTCCTT 82 59.4 2.0 JN381952.1 
EF1α TGATCTACAAGTGCGGAGGAA GGAGCCCTTTCCCATCTCA 80 58.4 2.0 AB075952.1 
Caspase-3 GGCTCTTCGTCTGCTTCTGT GGGAAATCGAGGCGGTATCT 80 59.4 2.1 GQ421464.1 
PCNA CCCTGGTGGTGGAGTACAAG AGAAGCCTCCTCATCGATCTTC 80 60.9 2.0 XM_003451046.2 
HSP70 ACCCAGACCTTCACCACCTA GTCCTTGGTCATGGCTCTCT 84 59.4 2.0 FJ213839.1 
TLR2 GCAGTGCCTTGAGTCTTGATC ACCGTGGAGATCGAGAACCT 101 59.6 2.1 XM_005460165 
TNFα CCAGAAGCACTAAAGGCGAAGA CCTTGGCTTTGCTGCTGATC 82 59.9 2.0 AY428948.1 
IL-1β TGGTGACTCTCCTGGTCTGA GCACAACTTTATCGGCTTCCA 86 58.7 2.1 XM_005457887.1 
TGFβ GTTTGAACTTCGGCGGTACTG TCCTGCTCATAGTCCCAGAGA 80 59.8 2.1 XM_003459454.2 
IL-10 CTGCTAGATCAGTCCGTCGAA GCAGAACCGTGTCCAGGTAA 94 59.6 2.1 XM_003441366.2 
 446 
 447 
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Table 4: Growth performance and final carcass composition of tilapia after six weeks of feeding on experimental diets. 448 
 
CON PRO-1.5 PRO-3 PRO-PULSE PRO-INI 
Initial weight (g fish-1) 29.42 ± 0.37 28.66 ± 0.25 29.10 ± 0.59 28.94 ± 0.03 29.42 ± 0.08 
Average weight (g fish-1 ) 68.20 ± 0.63a 68.83 ± 0.39ab 71.74 ± 0.83b 68.81 ± 0.04ab 67.57 ± 1.34a 
Weight gain (g fish-1) 38.78 ± 0.10a 40.17 ± 0.13ab 42.64 ± 0.23b 39.87 ± 0.06ab 38.15 ± 1.42a 
Feed intake (g fish-1) 53.46 ± 1.23 55.39 ± 0.57 56.42 ± 0.70 55.42 ± 0.05 54.91 ± 0.04 
PER 1.47 ± 0.15 1.47 ± 0.02 1.59 ± 0.02 1.44 ± 0.00 1.34 ± 0.10 
FCR (g g-1) 1.38 ± 0.07 1.38 ± 0.01 1.33 ± 0.01 1.39 ± 0.00 1.44 ± 0.06 
SGR (% day-1) 2.48 ± 0.06a 2.58 ± 0.01ab 2.66 ± 0.02b 2.55 ± 0.01ab 2.45 ± 0.06a 
Carcass proximate composition (%) 
Moisture 68.75 ± 0.44 68.97 ± 0.78 69.41 ± 0.89 69.81 ± 1.14 68.72 ± 0.59 
Ash*  9.88 ± 0.37 10.17 ± 0.49 9.67 ± 0.31 10.52 ± 0.74 10.20 ± 0.08 
Lipid*  34.68 ± 0.53 32.42 ± 0.78 34.94 ± 1.79 32.67 ± 1.68 33.78 ± 0.73 
Protein*  52.03 ± 0.42 53.41 ± 0.52 52.48 ± 1.50 54.43 ± 1.32 52.90 ± 1.38 
Energy* (MJ kg-1) 24.67 ± 0.17 24.39 ± 0.52 24.72 ± 0.53 24.56 ± 0.42 25.05 ± 0.19 
* Parameters reported as percentage of dry weight matter. 449 
a, b
 Different superscripts indicate a significant difference (P < 0.05).  450 
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Table 5: Histological data from the mid-intestine of tilapia fed control and AquaStar® Growout supplemented diets after six weeks of feeding on 451 
experimental diets.  452 
 CON PRO-1.5 PRO-3 PRO-PULSE PRO-INI 
Perimeter ratio (AU) 2.57 ± 0.58ab 2.03 ± 0.29a 3.16 ± 0.86b 2.94 ± 0.47ab 3.68 ± 0.72b 
IEL’s (per 100 µm) 34.04 ± 4.41a 37.39 ± 3.60ab 41.63 ± 2.66b 34.85 ± 2.99a 31.95 ± 1.61a 
Goblet cells (per 100 µm) 4.96 ± 1.53a 4.95 ± 0.91a 8.56 ± 0.82b 5.18 ± 0.64a 5.58 ± 1.33a 
a, b
 Different superscripts indicate a significant difference (P < 0.05). 453 
 454 
 455 
 456 
 457 
 458 
 459 
 460 
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Table 6: Allochthonous TVC, LAB, enterococci and Bacillus spp. (log CFU g-1) in the 461 
intestinal tract of tilapia after six weeks of feeding on experimental diets. 462 
 CON PRO-1.5 PRO-3 PRO-PULSE PRO-INI 
TVC 5.89 ± 0.59 5.92 ± 0.27 5.94 ± 0.28 6.01 ± 0.53 6.05 ± 0.51 
LAB 1.08 ± 1.34a 3.30 ± 1.86ab 5.39 ± 0.83b 2.45 ± 2.18ab n.da 
Bacillus spp. 4.30 ± 0.25ab 4.57 ± 0.22ab 5.18 ± 0.58b 3.87 ± 0.43a 4.10 ± 0.45ab 
Enterococci n.da 3.13 ± 1.72bc 5.03 ± 0.99c 0.94 ± 1.12ab n.da 
n.d = not detected 463 
a, b
 Different superscripts indicate a significant difference (P < 0.05). 464 
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Table 7: Microbial community analysis of the intestinal allochthonous bacterial populations of tilapia from DGGE fingerprints after six weeks of 
feeding on experimental diets. 
 Microbial ecological parameters  Similarity (ANOSIM)  
 N Richness Diversity SIMPER (%)   R- value P- value Dissimilarity (%) 
CON 17.75 ± 1.64 5.82 ± 0.39 2.87 ± 0.10 84.14 ± 7.35a      
PRO-1.5 15.25 ± 4.87 5.19 ± 1.19 2.67 ± 0.34 62.54 ± 15.42b      
PRO-3 13.00 ± 1.00 4.68 ± 0.25 2.56 ± 0.08 78.36 ± 8.88ab      
PRO-PULSE 19.25 ± 2.49 6.16 ± 0.57 2.95 ± 1.13 82.42 ± 4.37a      
PRO-INI 15.00 ± 1.41 5.17 ± 0.34 2.70 ± 0.09 72.81 ± 12.24ab      
Pairwise comparisons  
CON vs PRO-1.5       0.27 0.09 35.11 
CON vs PRO-3       1.00 0.03 53.35 
CON vs PRO-PULSE       0.37 0.06 20.84 
CON vs PRO-INI       0.17 0.11 23.64 
PRO-1.5 vs PRO-3       0.15 0.23 34.54 
PRO-1.5 vs PRO-PULSE       0.47 0.03 40.33 
PRO-1.5 vs PRO-INI       0.44 0.06 42.48 
PRO-3 vs PRO-PULSE       1.00 0.03 58.25 
PRO-3 vs PRO-INI       0.98 0.03 58.10 
PRO-PULSE vs PRO-INI       0.08 0.37 22.14 
N = number of operational taxonomic units; Richness = Margalef species richness; Diversity = Shannon’s diversity index; SIMPER = similarity 
percentage within group replicates. 
a, b
 Different superscripts indicate a significant difference (P < 0.05). 
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Highlights for manuscript “Dietary administration of a commercial mixed-species probiotic 
improves growth performance and modulates the intestinal immunity of tilapia, Oreochromis 
niloticus” 
• AquaStar® Growout improves the growth performance of juvenile tilapia. 
• AquaStar® Growout can augment mucosal tolerance. 
• AquaStar® Growout improves immune readiness. 
 
